Genetically Programmable Vesicles for Enhancing CAR‐T Therapy against Solid Tumors
Sign Up to like & getrecommendations! Published in 2023 at "Advanced Materials"
DOI: 10.1002/adma.202211138
Abstract: Chimeric antigen receptor‐T (CAR‐T) cell therapy has shown remarkable success in eradicating hematologic malignancies; however, its efficacy in treating solid tumors has always been limited due to the presence of an immune‐suppressive tumor microenvironment (TME).… read more here.
Keywords: tumor; apd nvs; car; genetically programmable ... See more keywords